GenSight Biologics S.A.

ENXTPA:SIGHT 株式レポート

時価総額:€32.9m

GenSight Biologics 将来の成長

Future 基準チェック /26

GenSight Biologics's earnings are forecast to decline at 49% per annum while its annual revenue is expected to grow at 33.5% per year. EPS is expected to decline by 57% per annum.

主要情報

-49.0%

収益成長率

-57.0%

EPS成長率

Biotechs 収益成長8.4%
収益成長率33.5%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日25 Oct 2024

今後の成長に関する最新情報

Recent updates

Is There An Opportunity With GenSight Biologics S.A.'s (EPA:SIGHT) 30% Undervaluation?

Dec 22
Is There An Opportunity With GenSight Biologics S.A.'s (EPA:SIGHT) 30% Undervaluation?

Is GenSight Biologics S.A. (EPA:SIGHT) Trading At A 39% Discount?

Sep 20
Is GenSight Biologics S.A. (EPA:SIGHT) Trading At A 39% Discount?

Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?

Aug 17
Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?

Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt

Aug 04
Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt

GenSight Biologics S.A. (EPA:SIGHT) Shares Could Be 27% Below Their Intrinsic Value Estimate

Jun 14
GenSight Biologics S.A. (EPA:SIGHT) Shares Could Be 27% Below Their Intrinsic Value Estimate

GenSight Biologics S.A. (EPA:SIGHT): Is Breakeven Near?

May 10
GenSight Biologics S.A. (EPA:SIGHT): Is Breakeven Near?

Analysts Expect Breakeven For GenSight Biologics S.A. (EPA:SIGHT) Before Long

Feb 02
Analysts Expect Breakeven For GenSight Biologics S.A. (EPA:SIGHT) Before Long

A Quick Analysis On GenSight Biologics' (EPA:SIGHT) CEO Salary

Dec 09
A Quick Analysis On GenSight Biologics' (EPA:SIGHT) CEO Salary

業績と収益の成長予測

ENXTPA:SIGHT - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20266-66-64-641
12/31/20257-36-34-342
12/31/20245-25-22-222
6/30/20242-20-16-16N/A
3/31/20242-23-20-20N/A
12/31/20233-26-25-25N/A
9/30/20233-28-29-29N/A
6/30/20233-29-33-33N/A
3/31/20234-28-34-34N/A
12/31/20225-28-34-34N/A
9/30/20225-29-29-29N/A
6/30/20225-31-24-24N/A
3/31/20226-30-20-20N/A
12/31/20218-29-17-17N/A
9/30/20219-28-18-18N/A
6/30/202111-28-19-19N/A
3/31/20219-31-17-17N/A
12/31/20207-34-15-15N/A
9/30/20207-31-15-15N/A
6/30/20206-28-15-15N/A
3/31/20205-30-22-22N/A
12/31/20195-31-28-28N/A
9/30/20195-35-32-31N/A
6/30/20195-39-35-35N/A
3/31/20195-36-32-32N/A
12/31/20184-33-29-28N/A
9/30/20184-30-25-25N/A
6/30/20184-26-21-21N/A
3/31/20184-25N/A-20N/A
12/31/20174-24N/A-19N/A
9/30/20173-23N/A-19N/A
6/30/20173-23N/A-20N/A
3/31/20173-22N/A-20N/A
12/31/20163-22N/A-20N/A
9/30/20163-20N/A-18N/A
6/30/20164-18N/A-17N/A
3/31/20164-16N/A-15N/A
12/31/20154-14N/A-12N/A
9/30/20153-11N/A-10N/A
6/30/20152-9N/A-7N/A
3/31/20152-8N/A-6N/A
12/31/20141-7N/A-6N/A
12/31/20131-3N/A-2N/A

アナリストによる今後の成長予測

収入対貯蓄率: SIGHT is forecast to remain unprofitable over the next 3 years.

収益対市場: SIGHT is forecast to remain unprofitable over the next 3 years.

高成長収益: SIGHT is forecast to remain unprofitable over the next 3 years.

収益対市場: SIGHT's revenue (33.5% per year) is forecast to grow faster than the French market (5.6% per year).

高い収益成長: SIGHT's revenue (33.5% per year) is forecast to grow faster than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: Insufficient data to determine if SIGHT's Return on Equity is forecast to be high in 3 years time


成長企業の発掘